Predictors of mortality at 3 months in patients with skull base tumor resections in a low-income setting.

Objective: Globally, skull base tumors are among the most challenging tumors to treat and are known for their significant morbidity and mortality. Hence, this study aimed to identify robust associated factors that contribute to mortality of patients following surgical resection for a variety of skull base tumors at the 3-month follow-up period. This in turn helps devise an evidence-based meticulous treatment strategy and baseline input for quality improvement work.

Starvation remains the leading cause of death in Tigray, northern Ethiopia, after the Pretoria deal: a call for expedited action.

Background: People in war-affected areas are more likely to experience excess mortality with hunger. However, information on the causes of death associated with hunger is often nonexistent. The purpose of this study was to verify and investigate hunger and hunger-related deaths after the Pretoria deal in Tigray, northern Ethiopia.

Bovine tuberculosis reactor cattle in Southwest Ethiopia: Risk factors for bovine tuberculosis.

Bovine tuberculosis, caused by , is a chronic zoonotic disease that persists in Ethiopia despite global control efforts, impacting public health and the economy. However, little is known about the epidemiology of bovine tuberculosis in Southwest Ethiopia. This study aims to assess the prevalence of bovine tuberculosis and identify associated risk factors in dairy cattle.

Predictors of operative ischemic cerebrovascular complications in skull base tumor resections: Experience in low-resource setting.

Background: Ischemic cerebrovascular complications following skull base tumor resections remain a significant factor impacting both short-term and long-term patient outcomes. This study aims to improve risk stratification, surgical decision-making, and postoperative care protocols.

Methods: A retrospective cohort study on predictors of ischemic cerebrovascular complications among patients who underwent skull base tumor resection was conducted at 2 high-volume neurosurgical centers in Ethiopia from 2018 to 2023.